Rabu, 30 Januari 2008

Personality Doesn't Sway Breast Cancer

Study Shows No Link Between Personality Traits and Breast Cancer Risk

By Miranda Hitti
WebMD Medical News

Reviewed By Louise Chang, MD

-- A woman's personality doesn't affect her odds of developing breast cancer, Dutch researchers report.

The findings may reassure patients that "their personality appears to have played no role in the development of their breast cancer," write Eveline Bleiker, PhD, of the Netherlands Cancer Institute, and colleagues.

They studied some 9,700 women aged 43 and older in the Dutch city of Nijmegen.

When the study began, none of the women had breast cancer. They completed personality surveys about traits including anxiety, anger, depression, optimism, and the ability to express emotions. They also answered questions about their breast cancer risk factors.

The women were followed for 13 years. During that time, 217 women were diagnosed with breast cancer.

The researchers found no personality differences between women who were and weren't diagnosed with breast cancer.

"Personality factors were not associated with the development of breast cancer," Bleiker's team writes in the Feb. 6 edition of the Journal of the National Cancer Institute.

About two years ago, another European study showed no link between personality and the odds of developing any type of cancer -- not just breast cancer. That study appeared in the Jan. 24, 2005, edition of Cancer.

SOURCES: Bleiker, E. Journal of the National Cancer Institute, pp 213-218. WebMD Medical News: "Personality Doesn't Affect Cancer Risk."

© 2008 WebMD Inc. All rights reserved.

Font Size
A
A
A

Health Tip: Risk Factors for Melanoma

(HealthDay News) - Melanoma is the most serious type of skin cancer. While it can be treated when caught early, it can spread and become deadly over time.

It is important to inspect your skin carefully and regularly to check for any new or changing moles or colored patches.

The Skin Cancer Foundation says you are at greater risk for melanoma if you have any of these risk factors:

  • Having prolonged or frequent exposure to the sun or UV rays, especially if you don't wear sunscreen.
  • Having a lot of moles.
  • Having fair skin.
  • Having a family history of melanoma.
  • Having been previously diagnosed with melanoma.
  • Having an immune system weakened by chemotherapy, a recent organ transplant, HIV/AIDS, or lymphoma.

-- Diana Kohnle

Copyright © 2008 ScoutNews, LLC. All rights reserved.

Font Size
A
A
A

Middle Age a Global Bummer

Across The Globe, People Are Happier Before, After Middle Age, Study Shows

By Miranda Hitti
WebMD Medical News

Reviewed By Louise Chang, MD

-- If life is a journey, happiness hits a speed bump in middle age for people worldwide, a new study shows.

But on the bright side, emotional well-being perks up again with age, according to the report.

Those findings come from more than 204,000 people in 72 countries. They rated their happiness or life satisfaction.

Around the world, from Austria to Zimbabwe, happiness ratings were higher before and after middle age. Picture a U-shaped curve, with middle age down in the valley of the U.

Getting Back to Happiness

U.S. men were almost 53 years old when they emerged from their midlife blues; U.S. women shifted back toward happiness earlier, when they were about 39 years old.

Those ages varied somewhat around the world, with the 40s as the turning point for men and women in Europe and developing countries.

The findings are based on adults of all ages. But participants weren't followed over time; the study was a snapshot of worldwide well-being.

Marriage, income, and education didn't explain the results. The impact of health on happiness wasn't part of the study.

The report comes from two economics professors: David Blanchflower, PhD, of Dartmouth College and Andrew Oswald, DPhil, of England's University of Warwick.

Why the Midlife Downturn?

The study doesn't show why happiness dips in midlife and picks back up again later. But the researchers have three theories:

  • People adapt to their strengths and weakness, ditching unrealistic expectations during middle age.
  • Cheerful people may live longer, making for more happiness later in life.
  • In middle age, a person may look around at others who have had a hard time and start to appreciate their own lives more.

Of course, the data paint a very broad picture. The findings don't mean that middle age is miserable for everyone.

The study is due to appear in an upcoming edition of Social Science & Medicine, according to a University of Warwick news release.

SOURCES: Blanchflower, D. Social Science & Medicine, 2008.
News release, University of Warwick.

© 2008 WebMD Inc. All rights reserved.

Diabetes' Health Toll Hits $174 Billion Annually

(HealthDay News) -- Diabetes-related medical and economic costs in the United States hit $174 billion in 2007, a 32 percent increase from 2002, a new study shows.

The research, commissioned by the American Diabetes Association (ADA), found medical care costs for people with diabetes were about $116 billion, and a disproportionate percentage of those costs resulted from the treatment and hospitalization of people with diabetes-related complications.

About one out of every five health-care dollars in the United States is spent caring for someone with diagnosed diabetes. Last year, diabetes caused more than 284,000 deaths in the United States.

"The findings reaffirm that diabetes is a public health crisis and its implications are painful and far-reaching," Ann L. Albright, president of health care and education at the ADA, said in a prepared statement. "This underscores the importance of early diagnosis and treatment. Diabetes becomes much more costly in financial and human terms when the disease is not properly treated."

The economic costs of diabetes in 2007 were estimated to be $58 billion, a figure that includes reduced productivity of both people in the labor force and unpaid workers, unemployment from diabetes-related disability, and increased absenteeism.

It's believed that about 6 million people in the United States have undiagnosed diabetes, which means the actual total cost of diabetes in 2007 may have been much more than $174 billion, the study said.

"Diabetes plagues more than just the individual with the disease. It is common, it is costly, it creates numerous complications, and there is no cure. Until we start reversing current trends, through increased awareness, prevention and aggressive disease management, diabetes will continue to have an adverse impact on our society as a whole," R. Stewart Perry, ADA's chairman of the board, said in a prepared statement.

The findings were discussed Wednesday at a Congressional briefing in Washington, D.C.

Allergy Shots Are Effective Treatment for Symptoms

(HealthDay News) -- If you have allergic asthma, rhinitis, conjunctivitis or stinging insect allergies, you may be a good candidate for allergy shots, also known as immunotherapy.

That's the recommendation of the American Academy of Allergy, Asthma & Immunology.

"Immunotherapy is a form of treatment that aims to decrease sensitivity to substances called allergens," Dr. Linda Cox, chair of the AAAAI's Immunotherapy and Allergy Diagnostics Committee, said in a prepared statement.

"Allergens, like pollen, mold or animal dander, are substances that trigger allergy symptoms when an allergic person is exposed to them. Patients who receive immunotherapy are injected with increasing amounts of an allergen until the target therapeutic dose is reached, in an effort to build resistance to specific allergens," Cox explained.

She said relief of allergy symptoms can last long after completion of treatment and that immunotherapy helps prevent the development of new allergies and may prevent the progression of allergic rhinitis to asthma.

Immunotherapy involves injections of gradually increasing doses of a particular allergen. Your body responds by developing immunity or tolerance to the allergen, resulting in decreased symptoms when you're exposed to the allergen.

While immunotherapy is recommended for people with allergic asthma, rhinitis, conjunctivitis and stinging insect allergies, it's not recommended for those with food allergies, the AAAAI said. The best option for people with food allergies is to avoid foods that pose a danger.

The AAAAI says people should see a doctor about immunotherapy if they:

  • Have a clear relationship between asthma, rhinitis, conjunctivitis, and exposure to an allergen,
  • Have a poor response to allergy medication or avoidance measures,
  • Have a long duration of allergy symptoms (most of the year),
  • Are a child with rhinitis, because of the potential role of allergen immunotherapy in the progression of allergic disease.

-- Robert Preidt

SOURCE: American Academy of Allergy, Asthma & Immunology, news release, January 2008

Copyright © 2008 ScoutNews, LLC. All rights reserved.

Antioxidant Pills Don't Cut Cancer Risk

Selenium May Benefit Men, but More Study Needed

By Salynn Boyles
WebMD Medical News

Reviewed By Louise Chang, MD

-- With one possible exception, many antioxidants in pill form do not appear to protect against cancer, according to pooled data from some of the most rigorous studies ever to examine the issue.

There was some evidence linking the mineral selenium to a reduced risk of cancer in men, but not in women. But the findings are not yet conclusive enough to recommend that men take selenium supplements, says Mayo Clinic physician Aditya Bardia, MD, MPH.

Bardia and colleagues combined 12 clinical trials including more than 100,000 participants for their systematic analysis, which appears in the January issue of the journal Mayo Clinic Proceedings.

Among their other major conclusions:

  • As previously reported, beta-carotene supplementation was found to be associated with an increased risk of cancer in smokers and a trend toward increased death rate from cancer.
  • Taking vitamin E supplements appeared to be of little benefit or harm with regard to cancer risk.

"Because we were able to pool the results from several different studies, we were able to show associations that individual studies might not show," Bardia tells WebMD.

Beta-Carotene and Lung Cancer

The analysis included two widely reported clinical trials published in the mid-1990s designed to determine if beta-carotene lowered lung cancer risk in smokers when combined with vitamins A or E.

Both studies showed an increased risk for lung cancer in smokers who took beta-carotene supplements.

Bardia says the evidence overall is now strong enough to recommend that smokers avoid beta-carotene supplements.

Based on this evidence, the health advocacy group Center for Science in the Public Interest (CSPI) last month petitioned the Food and Drug Administration to require labels on beta-carotene supplements warning smokers about the risk.

"Smokers are already at a high risk for lung cancer, and it appears that they are at even greater risk if they take beta-carotene supplements," CSPI senior nutritionist David Schardt tells WebMD. "Smokers need to know this, and it should be on the labels of these products."

Eat Your Fruits and Vegetables

The analysis did suggest a lower cancer risk in men who took selenium supplements, but the finding was based on the results of just three trials, and only one was of high quality, Bardia says.

Findings from two large, ongoing randomized trials assessing selenium supplementation for the prevention of prostate cancer should help clarify the issue, he adds.

Bardia also points out that the studies included in the analysis did not examine whether eating antioxidant-rich foods such as fruits, vegetables, and whole grains can lower cancer risk.

Many health groups, including the American Cancer Society (ACS), recommend consuming antioxidants through foods instead of supplements.

"It is an old-fashioned message but it is important to eat a variety of foods, including plenty of fruits and vegetables," ACS nutritional epidemiologist Marjorie McCullough, ScD, tells WebMD. "If people really would do this it would go a long way to ensuring that they get the nutrients and phytochemicals that may be important for reducing their cancer risk."

SOURCES: Bardia, A., Mayo Clinic Proceedings, January 2008; vol 83: pp 23-34. Aditya Bardia, MD, MPH, physician, Mayo Clinic, Rochester, Minn. David Schardt, senior nutritionist, Center for Science in the Public Interest. ACS: "Common Questions About Diet and Cancer," 2006. Marjorie L. McCullough, ScD, nutritional epidemiologist, American Cancer Society.

© 2008 WebMD Inc. All rights reserved.

Sex Hormones Don't Seem to Affect Prostate Cancer Risk

By Alan Mozes
HealthDay Reporter

(HealthDay News) -- A man's risk of prostate cancer is not related to the amount of sex hormones circulating in his bloodstream, a new British analysis suggests.

The conclusion was based on a review of 18 studies -- representing 95 percent of all available research -- that looked into potential links between the disease and blood hormone levels, the study authors said.

"There has been a long interest in whether or not natural variations in hormone levels in a man's blood are related to future disease risk," said study author Andrew Roddam, of the Cancer Research UK Epidemiology Unit at the University of Oxford. "What we have shown in this collaboration is that these natural fluctuations in levels of androgens [and estrogens] do not appear to be related to subsequent risk [for] the disease."

The findings were published online in the Jan. 29 issue of the Journal of the National Cancer Institute.

Prostate cancer is the most common type of cancer in American men, other than skin cancer. An estimated 220,000 new cases of prostate cancer were diagnosed in the United States in 2007, and about 27,000 men died from the disease, according to the American Cancer Society.

Although there's no single known cause of prostate cancer, risk is higher for those over the age of 50, black men, and those with a family history of the disease.

High levels of male sex hormones, known as androgens, have long been believed to be a risk factor for prostate cancer. To explore a possible hormone-cancer risk connection, Roddam and his colleagues analyzed data from studies that involved more than 10,000 men with and without prostate cancer. The research had been conducted between 1961 and 2001, and most study participants with prostate cancer had been diagnosed after the age of 60.

After compensating for other factors -- such as age, body-mass index, marital and educational status, smoking history and alcohol consumption -- the study authors found no statistical correlation between pre-diagnosis sex hormone concentrations in the bloodstream and the risk for developing prostate cancer.

Similarly, no hormone level combination -- such as a very high concentration of one sex hormone and a very low concentration of another -- was associated with prostate cancer risk.

In an accompanying editorial, co-author Dr. Paul A. Godley, an associate professor of medicine at the University of North Carolina School of Medicine, said the "impressive" findings could push prostate cancer research in a new direction.

"Researchers should redirect their attention toward investigations of potentially modifiable nutritional, lifestyle or environmental risk factors," he suggested, rather than target unchangeable factors -- such as blood hormone levels -- that do not appear to affect risk.

But, Dr. Peter T. Scardino, chairman of the department of surgery at Memorial Sloan-Kettering Cancer Center in New York City, cautioned that it would be wrong to conclude that male hormones have nothing to do with prostate cancer.

"This study asks if the amount of male or female hormones in your bloodstream can predict whether you will get prostate cancer, and the answer is no," he said. "But the prostate is like a sponge for hormones that sucks them out of circulation and converts them to even more powerful forms that can go to work in the prostate. So blood hormone levels may not have any connection with the amount of hormone in the prostate gland itself.

"The point is," he added, "I would not want people to think that altering the male hormone environment in the prostate has no effect. It certainly will. So if you take drugs like finestaride to shrink your prostate to urinate better, or Propecia to prevent balding, these drugs are working directly on hormone levels in the prostate, not the bloodstream. And these drugs work very well."

SOURCES: Andrew Roddam, Ph.D., Cancer Research UK Epidemiology Unit, University of Oxford, Great Britain; Paul A. Godley, M.D., Ph.D., departments of epidemiology and medicine, University of North Carolina School of Medicine, Chapel Hill; Peter T. Scardino, M.D., chairman, department of surgery, Memorial Sloan-Kettering Cancer Center, New York City; Jan. 29, 2008, Journal of the National Cancer Institute, online

Copyright © 2008 ScoutNews, LLC. All rights reserved.

Green Tea May Ward Off Weight Gain

But You'd Have to Drink a Lot of Tea to Match Preliminary Lab Tests in Mice

By Miranda Hitti
WebMD Medical News

Reviewed By Louise Chang, MD

-- The benefits of green tea might include blocking fat and keeping extra pounds at bay, according to preliminary lab tests in mice.

Don't skip over that word "preliminary." There's no proof yet that sipping green tea will do the same for people. Staying in shape continues to be a balancing act between calories and activity.

Here's what those preliminary lab tests in mice show:

  • Less weight and fat gain. Among mice with an obesity gene, those that ate chow laced with green tea extract gained less weight and less fat.
  • Less fat in the liver. There was less sign of "fatty liver" disease in the mice with the obesity gene that ate chow laced with green tea extract.
  • Lower cholesterol and triglyceride levels in mice with the obesity gene that ate the chow laced with green tea extract, compared to other mice with the same obesity gene.

A healthy liver isn't fatty. But obesity -- in mice or in people -- can lead to fatty buildup in the liver and cause nonalcoholic fatty liver disease.

As for that green tea extract, the study used it in doses equal to what a person would get from drinking at least seven cups of green tea a day.

The University of Connecticut's Richard Bruno, PhD, RD, and colleagues report their findings in February's edition of The Journal of Nutrition.

SOURCES: Bruno, R. The Journal of Nutrition, February 2008; vol 138: pp 323-333. News release, American Society for Nutrition.

© 2008 WebMD Inc. All rights reserved.

Yogurt Maker Sued Over Health Claims

Lawsuit Accuses Dannon of Deceptive Ads for Probiotic Activia and DanActive; Nutritionists Weigh In

By Miranda Hitti
WebMD Medical News

Reviewed By Louise Chang, MD

-- A class action lawsuit has been filed against the yogurt company Dannon over its marketing for yogurt products Activia and DanActive.

Activia is a yogurt marketed as being "clinically proven to help regulate the digestive system when eaten daily for two weeks," according to Activia's web site.

DanActive is a drink marketed as being "clinically proven to help strengthen the body's defense systems," states DanActive's web site.

Those claims focus on probiotics, which are healthy gut bacteria. There are many strains of probiotics; Activia and DanActive tout trademarked probiotic strains.

The lawsuit alleges a "massively deceptive" advertising campaign about those products' "clinically" and "scientifically" proven health benefits not available in other yogurts, states a news release from Coughlin Stoia Geller Rudman & Robbins LLP, the San Diego law firm that filed the lawsuit earlier this week.

Dannon countered with its own news release, in which Dannon says it "vigorously challenges this lawsuit" and "proudly stands by the claims of its products and the clinical studies which support them."

Nutritionists' Views

"Does this make yogurt a bad thing? No. If people want to eat yogurt, by all means, they should because you're getting nutrients in yogurt that you're not going to get in a pill," Leslie Bonci, MPH, RD, director of sports nutrition at the University of Pittsburgh Medical Center, tells WebMD.

WebMD Director of Nutrition Kathleen Zelman, MPH, RD, LD, agrees.

"Yogurt is good for you," Zelman says. She suggests that people who buy yogurt look for products that contain "live and active cultures or are enriched with additional healthy bacteria because there's sound science to document the healthfulness of those products."

But Bonci and Zelman say consumers shouldn't expect any yogurt to cure digestive disorders by itself.

Everybody probably won't find all their digestive problems solved by eating specialized yogurt products for two weeks, and "that may not be the yogurt's fault," Bonci says. "What else are they doing in their diet?

"I think if people are looking to maximize their digestive health, it's probably going to take more than a container of something that's in your refrigerator," she says.

Consuming enough fluids and fiber, being physically active, and controlling stress are also important for good digestive health, Bonci says.

SOURCES: News release, Coughlin Stoia Geller Rudman & Robbins LLP. News release, Dannon. Activia.com: "Activia Scientific Summary." DanActive.com: "DanActive Scientific Summary." DanActive.com: "L. casei Immunitas." Leslie Bonci, MPH, RD, director of sports nutrition, University of Pittsburgh Medical Center. Kathleen Zelman, MPH, RD, LD, director of nutrition, WebMD.

© 2008 WebMD Inc. All rights reserved.

Caffeine Risks May Rattle Diabetic People

Study Shows Caffeine Elevates Blood Glucose Levels in People With Diabetes

By Daniel J. DeNoon
WebMD Medical News

Reviewed By Louise Chang, MD

-- There's something about coffee that fights type 2 diabetes -- but it isn't caffeine.

Caffeine makes it hard for people with diabetes to control their blood sugar, new studies suggest.

In the latest of these studies, Duke University researcher James D. Lane, PhD, and colleagues put continuous blood-sugar monitors on 10 people with type 2 diabetes. All were regular coffee drinkers averaging four cups a day, but they stopped drinking coffee during the experiment.

On one day, each patient took a 250 mg caffeine capsule at breakfast and another 250 mg caffeine capsule at lunch. That's roughly the same as having them drink two cups of coffee at each meal. On another day, the same people got placebo pills with no caffeine in them.

The result: On the days the patients took caffeine, their blood-sugar levels were 8% higher. And after every meal -- including dinner -- their blood sugar spiked higher than it did on the day they had no caffeine.

"These are clinically significant blood-sugar elevations due to caffeine," Lane tells WebMD. "Caffeine increases blood glucose by as much as oral diabetes medications decrease it ... It seems the detrimental effects of caffeine are as bad as the beneficial effects of oral diabetes drugs are good."

Lane warns against reading too much into this small, 10-patient study. But he says it does show that caffeine has real effects on the everyday lives of people with diabetes.

"For people with diabetes, drinking coffee or consuming caffeine in other beverages may make it harder for them to control their glucose," he says.

Diabetes, Coffee, and Caffeine

Several studies have found that coffee drinkers -- especially those who drink a lot of coffee -- have a lower risk of diabetes than do other people. So how can coffee both protect against diabetes and worsen diabetes?

WebMD took this question to Harvard researcher Rob van Dam, PhD, who recently analyzed all of these studies.

"In 2002, we thought this did not make any sense," van Dam says. "This is quite a consistent observation, that coffee has a positive effect on diabetes. But it is becoming increasingly clear it is not the caffeine that is beneficial. The picture is now evolving where we see that some other components of coffee besides caffeine may be beneficial in long-term in reduction of diabetes risk."

In fact, van Dam says, it appears that decaf coffee may actually help people keep their blood sugar under control, whereas regular coffee has a detrimental effect on blood sugar. Caffeine unbalanced by other coffee compounds, he says, may be even worse.

Lane says that if there are anti-diabetes compounds in coffee, they don't offset the harmful effects of caffeine.

"We did do one study where we put caffeine in decaf coffee, and still we saw the same exaggeration of glucose after meals in people with diabetes," he says. "So it seems those other compounds in coffee certainly don't eliminate the caffeine effect we have seen."

So what should people do if they have diabetes or are at high risk of diabetes?

"We take a more nuanced posture -- not that coffee is good for you or bad for you, but that maybe it's better to switch to decaf coffee if you have diabetes or the metabolic syndrome," van Dam says.

Lane says people with diabetes are likely to get different effects from coffee.

"I am not going to say that everyone with diabetes has to quit drinking coffee, but I think those who are concerned about their blood sugar not being as low as they'd like it to be should try quitting coffee," he says. "They will be able to tell right away if it improves their glucose control. And it may help reduce their risk of complications of diabetes or reduce their need for additional diabetes medications."

For regular coffee drinkers, Lane says, quitting caffeine may mean three or four days of headache, sleepiness, or mental grogginess. But it does not mean interminable morning misery.

"Every morning we wake up in withdrawal, thinking we need coffee to wake us up -- but it really is just helping us get rid of withdrawal symptoms from not drinking coffee overnight," he says. "Once we get off, well, I wake up feeling better than I did when I was drinking coffee. I don't feel groggy or tired. Everyone I talk to has had a similar experience -- it is not that we become zombies after quitting drinking coffee."

Lane and colleagues report their findings in the February issue of Diabetes Care.

SOURCES: Lane, J.D. Diabetes Care, February 2008; vol 31, manuscript received ahead of publication. van Dam, R.M. Nutrition, Metabolism & Cardiovascular Disease, January 2006; vol 16: pp 69-77. Greenberg, J.A. American Journal of Clinical Nutrition, 2006; vol 84: pp 682-693. James D. Lane, PhD, professor of medical psychology, Duke University Medical Center, Durham, N.C. Rob M. van Dam, PhD, assistant professor of medicine, Harvard Medical School, Boston.

© 2008 WebMD Inc. All rights reserved.